Bioinformatics - Projects
|Analysis Engine||Michelle Gwinn-Giglio Ph.D.|
|CloVR||Owen White Ph.D.|
|Gemina||Lynn Schriml Ph.D.|
|GSCID||Claire M. Fraser Ph.D.|
|HMP DACC||Owen White Ph.D.|
As sequencing costs continue to drop it has become relatively easy to acquire the genome sequence of prokaryotic organisms. However, there are still few options available for doing systematic, complete annotation of the whole genome using a robust annotation pipeline. Funded by the National Institute of General Medical Sciences, the IGS Analysis Engine provides comprehensive annotation services along with all associated underlying data and tools for manual curation completely free-of-charge.
- Owen White Ph.D.
- Samuel V. Angiuoli, Ph.D.
The Cloud Virtual Resource (CloVR) takes advantage of two technologies, Virtual Machines and Cloud computing, to provide a new community resource for sequence analysis, suitable for large-scale sequencing projects. Bioinformatics sequence analysis still represents a major bottleneck for the application of genomics tools by the larger research community. CloVR aims to enable any researcher with a sequencing machine and an Internet connection to perform complex and computationally demanding sequence analysis and to join the genomic revolution. To achieve this, CloVR takes advantage of Cloud computing platforms that offer on-demand, scalable computing services over the Internet. The CloVR software is available as an Open Source virtual machine that bundles pre-installed and pre-configured bioinformatics tools into automated pipelines. With the CloVR virtual machine, users can run supported analysis on their desktop or laptop computers or utilize Cloud platforms to perform CPU-intensive tasks. CloVR will support common genomics applications for viral, prokyarotic, metagenomic and eukaryotic DNA and RNA sequencing projects. The first version of CloVR is intended to be released by the end of 2009.
Gemina is a web-based system designed to identify infectious pathogens and their representative genomic sequences through selection of associated epidemiology metadata. Gemina supports the development of DNA signature-based assays for the detection of pathogens or sets of pathogen through the Insignia Signature Pipeline at the University of Maryland.
The Genomic Sequencing Center for Infectious Disease will provide researchers with rapid and cost-efficient production of high-quality genome sequences of NIAID Category A-C priority pathogens, related organisms, clinical isolates, closely related species, and invertebrate vectors of infectious diseases and microorganisms responsible for emerging and re-emerging infectious diseases.
The Human Microbiome Project (HMP) is an international research initiative that will lay the foundation for future studies of human-associated microbial communities in health and disease. The HMP applies the techniques of metagenomics - the study of complex microbial communities using sequencing - to the analysis of microbial community structure and function. The HMP has outlined an ambitious set of goals that will ultimately answer such questions as whether or not humans share a core microbiome and how our microbial communities change over time in response to aging, disease, medications, lifestyle and other interventions.